Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Vaccinex, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 19 | −4 |
| SharesConverted for a 1-for-15 split | 188.3K | 2.58M | +2.40M (+1,272.4%) |
| Value | $994.8K | $2.92M | +$1.92M (+193.5%) |
New holders (5)
Institutions that held Vaccinex, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 680,000 | $768.4K | 0.02% |
| Millennium Management LLC | 13,757 | $15.5K | 0.00% |
| Tacita Capital Inc | 3,172 | $3.55K | 0.00% |
| Bank of America Corp | 67 | $76 | 0.00% |
| JPMorgan Chase & Co | 3 | $3 | 0.00% |
Sold out (9)
Institutions that held Vaccinex, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Citadel Advisors LLC | 103,084 | $36.7K |
| State Street Corp | 71,400 | $25.4K |
| Renaissance Technologies LLC | 46,276 | $16.0K |
| Northern Trust Corp | 23,369 | $8.32K |
| Vectors Research Management, LLC | 10,000 | $4.00K |
| Creative Planning | 11,000 | $3.92K |
| Courier Capital LLC | 10,000 | $3.56K |
| Moors & Cabot, Inc. | 10,000 | $3.56K |
| Financial Connections Group, Inc. | 4,044 | $1.00K |